Ms. Xiao is a partner based in the Beijing office. Ms Xiao’s practice focuses on securities, M&A and private equity investments.
Ms. Xiao is a partner based in the Beijing office. Ms Xiao’s practice focuses on securities, M&A and private equity investments.
Prior to joining Haiwen in April 2011, Ms Xiao worked at Jingtian & Gongcheng for about 3 years.
In the area of domestic capital markets, Ms. Xiao's experience in securities issuance includes advising issuers or underwriters in: the listing of Air China Cargo on the Main Board of SZSE, the listing of BMC Medical on the Growth Enterprise Market of SZSE, the listing of Anlogic Infotech on the SSE STAR Market, the listing of CICC on the Main Board of SSE, the listing of Postal Savings Bank of China on the Main Board of SSE, the listing of Bank of Xi'an on the Main Board of SSE, the listing of Yusys Technologies on the Growth Enterprise Market of the Shenzhen Stock Exchange, the listing of Beingmate on the Small and Medium-sized Enterprise Market of SZSE, and the listing of PetroChina on the Main Board of SSE, the private placement of Do-Fluoride New Materials (002407.SZ) in 2023, and the private placement of Xiamen Xindeco Ltd (000701.SZ) in 2023, etc.
In the area of overseas capital markets, Ms. Xiao's experience in securities issuance includes advising issuers or underwriters in: the H share IPO of Geek+,the H share IPO of China CDF, the H share IPO of Bank of Jiujiang, the H share IPO of Postal Savings Bank of China, the H share IPO of CICC, the H share IPO of Bank of Qingdao, the H share IPO of Bank of Jinzhou, the H share IPO of Bank of Chongqing, the listing of Sany Heavy Equipment on HKEx with a red-chip model，the listing of Dah Chong Hong on HKEx, the secondary listing of SouthGobi on HKEx, the listing of Rise Education on NASDAQ, the issuance of US$2 billion convertible bonds and warrants of Lenovo Group Limited in 2025, the private placement of H shares of Fuyao Group in 2021, the private placement of offshore preferred shares of Postal Savings Bank of China in 2017, the follow-on offering of Rise Education in 2018，the issuance of offshore USD bonds of Easyhome New Retail in 2018, and the issuance of offshore USD bonds of Taikang Group in 2016, etc.
In the area of public M&A transaction, Ms. Xiao's recent experience includes advising: Beijing State-owned Assets Company in restructuring and establishing Beijing Data Group, involving the acquisition of its A-share listed companies and H-share listed companies, CITIC Securities International Company Limited in connection with its sale of 40% equity of CLSA Premium, China Development Bank Capital in connection with its sale of 29.9% equity of China New Town, CICC in connection with its asset restructuring and business restructuring with its subsidiary CICC Fortune Securities, the financial advisor in connection with the merger and restructuring of China COSCO and China COSCO Shipping, the financial advisor in connection with the merger of CSR and CNR into CRRC, EC-Founder in connection with its issuance of shares and CB to its controlling shareholder to acquire the onshore real estate businesses, the controlling shareholder of Loongson Technology (688047.SH) in increasing its stake through secondary market, Qatar Airways in increasing its stake in China Southern Airlines(600029.SH，01055.HK) by 5% through secondary market, etc.
In the area of private investment or acquisition transactions, Ms. Xiao's recent experience includes advising: SDIC Gaoxin in its acquisition of OBTC, SDIC Gaoxin in connection with its equity diversification reform, China Guangfa Bank in its share capital increase in 2018, Sinopec Marketing Co., Ltd. In connection with its private placement of RMB 100 billion in shares, Doing Now in its acquisition of Cinderella Beijing and Aishang Taekwondo, Changyou.com in its acquisition of the 7Road. Com, Baosteel Group in its acquisition and restructuring of Guangzhou Steel Group and Shaoguan Steel Group, Future Capital in its various investments, Caogen Capital in its investment in iNature Biotech, China Capital Investment Group in its investment in Kuanteng Medical, Ant Group in its investment in SeekTruth, Taikang Life Insurance for its strategic investment in China Merchants Highway, Hillhouse in its investment in KE's Series D financing, China Renaissance in its investment in Sumscope, a certain investor in its investment in Ant's Series C financing, Yusys Technology in its investment in Dalian Tongfang Softbank, Yuxin Fund in its investment in Windawn, Cornerstone Capital in its investment in EFT Intelligent Equipment, IDG in its investment in Bama Tea, IDG in its investment in GREEN Farm Co., Ltd., CDH in its investment in a food production company, Goldstone in its investment in Megmeet, and CPE in its investment in Western Gold, etc.
Ms. Xiao has been recognized on the 2025-26 “A-List: Growth Drivers” list by China Business Law Journal.
Ms. Xiao has participated in writing Research on Difficult Problems in New Types of Corporate Litigation.
Ms. Xiao is a member of a council of China Business Law Society.
Ms. Xiao received her LL.B. degree and B.S. in Economics (Dual Degree) in 2006 and her Master of Laws degree in 2008 from Peking University.
Ms. Xiao's native language is Mandarin, and he speaks English fluently.
Beijing ICP No. 05019364-1 Beijing Public Network Security 110105011258